CDR2 antibody (N-Term)
Quick Overview for CDR2 antibody (N-Term) (ABIN629700)
Target
See all CDR2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- CDR2 antibody was raised against the N terminal of CDR2
-
Purification
- Purified
-
Immunogen
- CDR2 antibody was raised using the N terminal of CDR2 corresponding to a region with amino acids MLAENLVEEFEMKEDEPWYDHQDLQQDLQLAAELGKTLLDRNTELEDSVQ
-
-
-
-
Application Notes
-
WB: 5 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
CDR2 Blocking Peptide, (ABIN5612802), is also available for use as a blocking control in assays to test for specificity of this CDR2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CDR2 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- CDR2 (Cerebellar Degeneration-Related Protein 2, 62kDa (CDR2))
-
Alternative Name
- CDR2
-
Background
- Cdr2 normally sequesters c-Myc in the neuronal cytoplasm, thereby down-regulating c-Myc activity, and suggest a mechanism whereby inhibition of cdr2 function by autoantibodies in PCD may contribute to Purkinje neuronal.
-
Molecular Weight
- 52 kDa (MW of target protein)
Target
-